H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Biohaven Pharmaceutical Holding Co (NYSE:BHVN) Ltd on Tuesday,... H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on ...
With the popular social media app once again at risk of going dark, there are best practices pharma brands can use on other ...
H.C. Wainwright analyst Douglas Tsao reiterated a Buy rating on Biohaven Pharmaceutical Holding Co (NYSE:BHVN) Ltd on Tuesday,... Wedbush analyst Laura Chico maintained a Buy rating on Biohaven ...
Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...
Discover the strengths & weaknesses of healthcare giants Johnson & Johnson and Pfizer. Find out which stock is more promising for long-term investors.
Robert Lenz is leaving the brain drug developer to “pursue other interests.” Elsewhere, Atara is cutting half of its staff after shelving two cell therapy programs.
Bernstein analyst William Pickering maintained a Hold rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday and set a price ...
Piper Sandler analyst Allison Bratzel maintained a Buy rating on Biohaven Ltd. (BHVN – Research Report) today and set a price target of ...
Michigan Attorney General Dana Nessel has announced that Michigan has joined the U.S. Department of Justice, 37 other states, and Puerto Rico in settling kickback allegations against Biohaven ...
The challenge of the obesity epidemic is widespread and one that even pediatricians face constantly,” a Connecticut doctor ...
Biohaven Pharmaceutical (BHVN) 71% HIGHER; Pfizer Inc. (NYSE:PFE) and Biohaven Pharmaceutical Holding... Hims & Hers Health, Inc. (HIMS) reported Q1 EPS of ($0.08), $0.01 worse than the analyst ...
The Department of Justice (DoJ) claims that Biohaven – before being acquired ... will use every tool at its disposal to prevent pharmaceutical manufacturers from undermining the objectivity ...